Britain can’t afford to lose AstraZeneca
It has already cancelled investments in Liverpool and Cambridge, while muttering darkly about moving its listing to New York and its headquarters to the United States. Now AstraZeneca, the UK’s largest pharmaceutical company, is threatening to stop investing in Britain completely if the country does not spend more on medicine. There may be an element
